Last 12 months
Inside the activity.
0 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 35 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 9 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2020 Filed Mar 10, 2020 20:05 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionCommon Stock | 2,000 | $33.42 | $66,840.00 |
DisclosureSEC source: 0001237899-20-000014 · edgardoc.xml · nonDerivative · entry 1 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 21:00 UTC |
Sanofi10% owner
|
SaleCommon Stock | 128,914 | $489.65 | $63,123,152.62 |
DisclosureSEC source: 0001140361-20-005506 · form4.xml · nonDerivative · entry 1 Sanofi · CIK 0001121404 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,421,899 F1 · kind: Private sale to the Issuer pursuant to the letter agreement entered into with the Issuer on January 7, 2018 and filed on January 9, 2018 by the Reporting Person as Exhibit 99.4 to Amendment No. 13 to Reporting Person's statement on Schedule 13D. F3 · ownership.direct: Pursuant to the Amended and Restated Investor Agreement, dated as of January 11, 2014, by and among the Reporting Person, sanofi-aventis US LLC, Aventis, sanofi-aventis Amerique du Nord (collectively, the "Sanofi Parties") and the Issuer, the Sanofi Parties have agreed to vote their respective shares of the Issuer, subject to specified exceptions, in accordance with the recommendation of the Issuer's Board of Directors. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 20:06 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001708138-20-000022 · edgardoc.xml · derivative · entry 4 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2020-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · derivative.exercise_date: With respect to 96,736 underlying shares, the option award vested in four equal annual installments, commencing one year after the date of grant; and with respect to 150,000 underlying shares, the option became exercisable on December 31, 2013, based upon the satisfaction by the Company of certain performance criteria during the period ended December 31, 2013. F3 · balance_after: Form two of two Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 20:06 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 96,736 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001708138-20-000022 · edgardoc.xml · derivative · entry 3 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 96,736 shares Expires 2020-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · derivative.exercise_date: With respect to 96,736 underlying shares, the option award vested in four equal annual installments, commencing one year after the date of grant; and with respect to 150,000 underlying shares, the option became exercisable on December 31, 2013, based upon the satisfaction by the Company of certain performance criteria during the period ended December 31, 2013. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
Tax withholdingCommon Stock | 78,376 | $476.42 | $37,339,893.92 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 4 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,614 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
Exercise / conversionCommon Stock | 150,000 | $30.63 | $4,594,500.00 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 3 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713,990 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
Tax withholdingCommon Stock | 50,545 | $476.42 | $24,080,648.90 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 2 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563,990 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
Exercise / conversionCommon Stock | 96,736 | $30.63 | $2,963,023.68 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 1 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 614,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 31 | $468.56 | $14,525.36 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 30 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,380 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F24 · balance_after: Form one of two Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 227 | $465.42 | $105,650.34 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 29 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,411 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F23 · price: Represents volume-weighted average price of sales of 227 shares of Company stock on February 27, 2020 at prices ranging from $465.04 to $465.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 126 | $464.14 | $58,481.64 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 28 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,638 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F22 · price: Represents volume-weighted average price of sales of 126 shares of Company stock on February 27, 2020 at prices ranging from $464.13 to $464.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 123 | $463.10 | $56,961.30 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 27 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,764 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 1 | $462.15 | $462.15 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 26 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,887 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 614 | $461.24 | $283,201.36 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 25 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,888 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F21 · price: Represents volume-weighted average price of sales of 614 shares of Company stock on February 27, 2020 at prices ranging from $461.00 to $461.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 252 | $460.34 | $116,005.68 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 24 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,502 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F20 · price: Represents volume-weighted average price of sales of 252 shares of Company stock on February 27, 2020 at prices ranging from $460.02 to $460.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 692 | $459.47 | $317,953.24 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 23 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,754 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F19 · price: Represents volume-weighted average price of sales of 692 shares of Company stock on February 27, 2020 at prices ranging from $459.09 to $459.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 460 | $458.59 | $210,951.40 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 22 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,446 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F18 · price: Represents volume-weighted average price of sales of 460 shares of Company stock on February 27, 2020 at prices ranging from $458.31 to $458.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 141 | $457.27 | $64,475.07 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 21 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,906 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F17 · price: Represents volume-weighted average price of sales of 141 shares of Company stock on February 27, 2020 at prices ranging from $457.11 to $457.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 743 | $456.63 | $339,276.09 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 20 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,047 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F16 · price: Represents volume-weighted average price of sales of 743 shares of Company stock on February 27, 2020 at prices ranging from $456.10 to $456.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 2,967 | $455.56 | $1,351,646.52 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 19 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,790 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F15 · price: Represents volume-weighted average price of sales of 2,967 shares of Company stock on February 27, 2020 at prices ranging from $455.11 to $455.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 102 | $454.58 | $46,367.16 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 18 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,757 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F14 · price: Represents volume-weighted average price of sales of 102 shares of Company stock on February 27, 2020 at prices ranging from $454.58 to $454.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 113 | $453.45 | $51,239.85 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 17 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,859 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 130 | $452.08 | $58,770.40 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 16 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,972 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 233 | $451.47 | $105,192.51 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 15 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,102 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F13 · price: Represents volume-weighted average price of sales of 233 shares of Company stock on February 27, 2020 at prices ranging from $451.07 to $451.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 125 | $450.10 | $56,262.50 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 14 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,335 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 236 | $449.53 | $106,089.08 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 13 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,460 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F12 · price: Represents volume-weighted average price of sales of 236 shares of Company stock on February 27, 2020 at prices ranging from $449.25 to $449.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 240 | $448.86 | $107,726.40 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 12 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,696 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F11 · price: Represents volume-weighted average price of sales of 240 shares of Company stock on February 27, 2020 at prices ranging from $448.73 to $448.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 120 | $445.91 | $53,509.20 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 11 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,936 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F10 · price: Represents volume-weighted average price of sales of 120 shares of Company stock on February 27, 2020 at prices ranging from $445.91 to $445.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 490 | $444.65 | $217,878.50 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 10 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,056 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F9 · price: Represents volume-weighted average price of sales of 490 shares of Company stock on February 27, 2020 at prices ranging from $444.35 to $444.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 264 | $443.67 | $117,128.88 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 9 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,546 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F8 · price: Represents volume-weighted average price of sales of 264 shares of Company stock on February 27, 2020 at prices ranging from $443.49 to $443.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 395 | $440.24 | $173,894.80 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 8 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,810 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F7 · price: Represents volume-weighted average price of sales of 395 shares of Company stock on February 27, 2020 at prices ranging from $440.05 to $440.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 231 | $439.73 | $101,577.63 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 7 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,205 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F6 · price: Represents volume-weighted average price of sales of 231 shares of Company stock on February 27, 2020 at prices ranging from $439.72 to $439.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 256 | $438.63 | $112,289.28 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 6 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,436 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · price: Represents volume-weighted average price of sales of 256 shares of Company stock on February 27, 2020 at prices ranging from $438.58 to $438.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 480 | $437.41 | $209,956.80 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 5 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,692 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · price: Represents volume-weighted average price of sales of 480 shares of Company stock on February 27, 2020 at prices ranging from $437.16 to $437.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 348 | $436.43 | $151,877.64 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 4 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,172 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · price: Represents volume-weighted average price of sales of 348 shares of Company stock on February 27, 2020 at prices ranging from $436.30 to $436.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:40 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 209 | $435.93 | $91,109.37 |
DisclosureSEC source: 0001708138-20-000017 · edgardoc.xml · nonDerivative · entry 3 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,520 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 209 shares of Company stock on February 27, 2020 at prices ranging from $435.90 to $435.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2020 at each separate price. Read SEC document |
| February 26, 2020 Filed Feb 26, 2020 23:14 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 34 | $460.05 | $15,641.70 |
DisclosureSEC source: 0001708138-20-000012 · edgardoc.xml · nonDerivative · entry 22 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,973 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F9 · price: Represents volume-weighted average price of sales of 34 shares of Company stock on February 26, 2020 at prices ranging from $460.03 to $460.07. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price. Read SEC document |
| February 26, 2020 Filed Feb 26, 2020 23:14 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 27 | $458.35 | $12,375.45 |
DisclosureSEC source: 0001708138-20-000012 · edgardoc.xml · nonDerivative · entry 21 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,007 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F8 · price: Represents volume-weighted average price of sales of 27 shares of Company stock on February 26, 2020 at prices ranging from $458.11 to $458.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price. Read SEC document |
| February 26, 2020 Filed Feb 26, 2020 23:14 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 25 | $457.23 | $11,430.75 |
DisclosureSEC source: 0001708138-20-000012 · edgardoc.xml · nonDerivative · entry 20 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,034 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F7 · price: Represents volume-weighted average price of sales of 25 shares of Company stock on February 26, 2020 at prices ranging from $457.10 to $457.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price. Read SEC document |
| February 26, 2020 Filed Feb 26, 2020 23:14 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 10 | $456.67 | $4,566.70 |
DisclosureSEC source: 0001708138-20-000012 · edgardoc.xml · nonDerivative · entry 19 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,059 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 26, 2020 Filed Feb 26, 2020 23:14 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 32 | $455.37 | $14,571.84 |
DisclosureSEC source: 0001708138-20-000012 · edgardoc.xml · nonDerivative · entry 18 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,069 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F6 · price: Represents volume-weighted average price of sales of 32 shares of Company stock on February 26, 2020 at prices ranging from $455.24 to $455.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price. Read SEC document |
| February 26, 2020 Filed Feb 26, 2020 23:14 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 18 | $454.85 | $8,187.30 |
DisclosureSEC source: 0001708138-20-000012 · edgardoc.xml · nonDerivative · entry 17 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,101 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 26, 2020 Filed Feb 26, 2020 23:14 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 44 | $453.36 | $19,947.84 |
DisclosureSEC source: 0001708138-20-000012 · edgardoc.xml · nonDerivative · entry 16 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,119 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · price: Represents volume-weighted average price of sales of 44 shares of Company stock on February 26, 2020 at prices ranging from $453.04 to $453.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price. Read SEC document |
| February 26, 2020 Filed Feb 26, 2020 23:14 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 10 | $452.04 | $4,520.40 |
DisclosureSEC source: 0001708138-20-000012 · edgardoc.xml · nonDerivative · entry 15 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,163 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 21:12 UTC |
Van Plew Daniel PEVP & General Mgr Industrial O
|
SaleCommon Stock | 210 | $460.30 | $96,663.00 |
DisclosureSEC source: 0001708138-20-000014 · edgardoc.xml · nonDerivative · entry 12 Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr Industrial O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,251 F10 · price: Represents volume-weighted average price of sales of 210 shares of Company stock on February 26, 2020 at prices ranging from $460.00 to $460.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 21:12 UTC |
Van Plew Daniel PEVP & General Mgr Industrial O
|
SaleCommon Stock | 1,425 | $459.33 | $654,545.25 |
DisclosureSEC source: 0001708138-20-000014 · edgardoc.xml · nonDerivative · entry 11 Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr Industrial O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,461 F9 · price: Represents volume-weighted average price of sales of 1,425 shares of Company stock on February 26, 2020 at prices ranging from $459.02 to $459.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 21:12 UTC |
Van Plew Daniel PEVP & General Mgr Industrial O
|
SaleCommon Stock | 5,274 | $458.45 | $2,417,865.30 |
DisclosureSEC source: 0001708138-20-000014 · edgardoc.xml · nonDerivative · entry 10 Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr Industrial O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,886 F8 · price: Represents volume-weighted average price of sales of 5,274 shares of Company stock on February 26, 2020 at prices ranging from $458.00 to $458.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 21:12 UTC |
Van Plew Daniel PEVP & General Mgr Industrial O
|
SaleCommon Stock | 3,787 | $457.59 | $1,732,893.33 |
DisclosureSEC source: 0001708138-20-000014 · edgardoc.xml · nonDerivative · entry 9 Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr Industrial O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,160 F7 · price: Represents volume-weighted average price of sales of 3,787 shares of Company stock on February 26, 2020 at prices ranging from $457.00 to $457.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 21:12 UTC |
Van Plew Daniel PEVP & General Mgr Industrial O
|
SaleCommon Stock | 1,435 | $456.50 | $655,077.50 |
DisclosureSEC source: 0001708138-20-000014 · edgardoc.xml · nonDerivative · entry 8 Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr Industrial O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,947 F6 · price: Represents volume-weighted average price of sales of 1,435 shares of Company stock on February 26, 2020 at prices ranging from $456.00 to $456.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 21:12 UTC |
Van Plew Daniel PEVP & General Mgr Industrial O
|
SaleCommon Stock | 1,300 | $455.50 | $592,150.00 |
DisclosureSEC source: 0001708138-20-000014 · edgardoc.xml · nonDerivative · entry 7 Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr Industrial O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,382 F5 · price: Represents volume-weighted average price of sales of 1,300 shares of Company stock on February 26, 2020 at prices ranging from $455.01 to $455.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.